Novo Nordisk and Eli Lilly Expected to Lead Global New Drug Sales in 2024
According to a recent report from Evaluate, Novo Nordisk and Eli Lilly are expected to lead in global new drug sales in 2024. The booming demand for blood sugar-modulating diabetes and obesity drugs has propelled these two companies to dominate…
Tirzepatide vs. Semaglutide: A Comparison
There has been a lot of buzz in the weight loss space with the emergence of medications like tirzepatide and semaglutide. But what’s the deal with tirzepatide vs. semaglutide? Let’s dive into the details. At a basic level, tirzepatide, also…